Dr. Li is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
333 Providence Hwy
Boston Biomedical, Inc.
Norwood, MA 02062Phone+1 781-278-0846Fax+1 781-762-9863
Education & Training
Beth Israel Deaconess Medical CenterFellowship, Gastroenterology, 2001 - 2004
Brigham and Women's HospitalResidency, Internal Medicine, 1998 - 2001
Harvard Medical SchoolClass of 1998
Publications & Presentations
PubMed
- 83 citationsInduction of cancer cell stemness by chemotherapyXingwang Hu, Laura Ghisolfi, Andrew C. Keates, Jian Zhang, Shuanglin Xiang
Cell Cycle. 2012-07-15 - 357 citationsSuppression of cancer relapse and metastasis by inhibiting cancer stemnessYouzhi Li, Harry A. Rogoff, Sarah Keates, Yuan Gao, Sylaja Murikipudi
Proceedings of the National Academy of Sciences of the United States of America. 2015-02-10 - 29 citationsCarvedilol in glioma treatment alone and with imatinib in vitroMine Erguven, Nuray Yazihan, Esin Aktas, Akin Sabanci, Chiang J Li
International Journal of Oncology. 2010-04-01
Press Mentions
The End of Toxic Chemo and RadiationDecember 23rd, 2019
Boston Biomedical Presents Clinical Data on First-in-Class Cancer Stemness Inhibitor Napabucasin at 2017 ASCO GI SymposiumJanuary 21st, 2017- Boston Biomedical Presents Clinical Data on First-in-Class Cancer Stemness Inhibitor Napabucasin at 2017 ASCO GI SymposiumJanuary 21st, 2017
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
